Anixa Biosciences Inc.

Last updated September 27, 2026

Organization details

Legal name
Anixa Biosciences Inc.
Former names
ITUS Corp Copytele Inc
Ownership
Public
Status
Active
Sector (GICS)
Health Care
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
SAN Jose
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
October
Ticker symbol
ANIX
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0000715446
EIN
11-2622630

Board of directors

Chief executives

Amit Kumar · Chief Executive Officer
Dates unknown

Director election results

Annual meeting of March 10, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$521,772
21 purchases by 4 insiders
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Oct 30, 2026 Amit Kumar Director, Officer (Chief Executive Officer) Open-market purchase +5,000 $3.17 $15,850
Oct 23, 2026 Lewis H. Titterton Jr. Director Open-market purchase +8,000 $2.98 $23,840
Oct 22, 2026 Amit Kumar Director, Officer (Chief Executive Officer) Open-market purchase +8,000 $2.72 $21,760
Sep 30, 2026 Catelani Michael Officer (President, COO, & CFO) Open-market purchase +5,500 $2.84 $15,620
Sep 24, 2026 Arnold M. Baskies Director Open-market purchase +5,000 $2.76 $13,800
Sep 24, 2026 Amit Kumar Director, Officer (Chief Executive Officer) Open-market purchase +7,000 $2.78 $19,460
Sep 23, 2026 Lewis H. Titterton Jr. Director Open-market purchase +49,036 $2.69 $131,907
Sep 10, 2026 Amit Kumar Director, Officer (Chief Executive Officer) Open-market purchase +5,000 $2.76 $13,800
Sep 10, 2026 Lewis H. Titterton Jr. Director Open-market purchase +10,000 $2.73 $27,300
Sep 10, 2026 Amit Kumar Director, Officer (Chief Executive Officer) Open-market purchase +3,000 $2.75 $8,250
Jul 31, 2026 Amit Kumar Director, Officer (Chief Executive Officer) Open-market purchase +5,000 $3.47 $17,350
Jul 27, 2026 Amit Kumar Director, Officer (Chief Executive Officer) Open-market purchase +3,188 $3.37 $10,744
Jul 27, 2026 Amit Kumar Director, Officer (Chief Executive Officer) Open-market purchase +5,000 $3.44 $17,200
Jul 27, 2026 Arnold M. Baskies Director Option exercise +6,000 $3.13 $18,780
Jul 27, 2026 Arnold M. Baskies Director Shares withheld for tax −5,428 $3.46 $18,781

Organizations in the same sector, closest in location and size first.

Questions about Anixa Biosciences Inc.

Who is the CEO of Anixa Biosciences Inc.?

Amit Kumar is Anixa Biosciences Inc.'s Chief Executive Officer.

How many directors are on Anixa Biosciences Inc.'s board?

Anixa Biosciences Inc.'s board has 4 directors: Amit Kumar, Arnold M. Baskies, Emily Gottschalk and Lewis H. Titterton Jr.

Are Anixa Biosciences Inc. insiders buying or selling shares?

Over the last 12 months, Anixa Biosciences Inc. insiders bought $521,772 of shares in 21 purchases and made no open-market sales on the open market, as reported to the SEC on Forms 4 and 5.

Embed this board on your site

Paste this where the board should appear. It always shows the current directors and links back here.

<div data-bod-board="anixa-biosciences-inc"></div>
<script src="https://boardofdirectors.review/embed.js" async></script>

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.